Methylglyoxal Metabolism and Aging-Related Disease: Moving from Correlation toward Causation

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperReviewResearchpeer-review

100 Citations (Scopus)

Abstract

Methylglyoxal (MG) is a ubiquitous metabolite that spontaneously reacts with biopolymers forming advanced glycation end-products (AGEs). AGEs are strongly associated with aging-related diseases, including cancer, neurodegenerative diseases, and diabetes. As the formation of AGEs is nonenzymatic, the damage caused by MG and AGEs has been regarded as unspecific. This may have resulted in the field generally been regarded as unappealing by many researchers, as detailed mechanisms have been difficult to probe. However, accumulating evidence highlighting the importance of MG in human metabolism and disease, as well as data revealing how MG can elicit its signaling function via specific protein AGEs, could change the current mindset, accelerating the field to the forefront of future research.

Original languageEnglish
JournalTrends in Endocrinology and Metabolism
Volume31
Issue2
Pages (from-to)81-92
Number of pages12
ISSN1043-2760
DOIs
Publication statusPublished - 2020

Keywords

  • AGE
  • aging-related disease
  • diabetes
  • GLO1
  • hormesis
  • methylglyoxal

Fingerprint

Dive into the research topics of 'Methylglyoxal Metabolism and Aging-Related Disease: Moving from Correlation toward Causation'. Together they form a unique fingerprint.

Cite this